Proactive clinical review of patients taking opioid medicines long-term for persistent pain led by clinical pharmacists in primary care teams feasibility study
- Conditions
- Chronic painMusculoskeletal DiseasesPatients prescribed opioids for 6 months or longer for persistent non-cancer pain
- Registration Number
- ISRCTN87628403
- Lead Sponsor
- Keele University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 148
Prescribed any opioid analgesic (defined as any opioid or opioid/paracetamol combination analgesic from sections 4.7.2 and 4.7.1 British National Formulary[ref ]) for chronic non-cancer pain continuously for =6 months, (= one 28-day opioid prescription issued at least every two months in previous 6 months)
1. Acute pain
2. Cancer pain
3. Terminal illness (life expectancy < 6 months)
4. Vulnerable patients (e.g. severe mental illness, learning difficulties, dementia)
5. Current treatment for substance misuse
6. Unable to understand English
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method